0002028346-24-000001.txt : 20240626 0002028346-24-000001.hdr.sgml : 20240626 20240626120911 ACCESSION NUMBER: 0002028346-24-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20240626 DATE AS OF CHANGE: 20240626 EFFECTIVENESS DATE: 20240626 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Elion Therapeutics, Inc. CENTRAL INDEX KEY: 0002028346 ORGANIZATION NAME: IRS NUMBER: 823453095 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-516941 FILM NUMBER: 241072063 BUSINESS ADDRESS: STREET 1: C/O DEERFIELD MANAGEMENT COMPANY LP STREET 2: 345 PARK AVENUE SOUTH CITY: NEW YORK STATE: NY ZIP: 10010 BUSINESS PHONE: 212-551-1600 MAIL ADDRESS: STREET 1: C/O DEERFIELD MANAGEMENT COMPANY LP STREET 2: 345 PARK AVENUE SOUTH CITY: NEW YORK STATE: NY ZIP: 10010 D 1 primary_doc.xml X0708 D LIVE 0002028346 Elion Therapeutics, Inc. C/O DEERFIELD MANAGEMENT COMPANY LP 345 PARK AVENUE SOUTH NEW YORK NY NEW YORK 10010 212-551-1600 DELAWARE Sfunga Therapeutics, Inc. None Corporation true Kieren Marr c/o Deerfield Management Company LP 1345 Park Avenue South New York NY NEW YORK 10010 Executive Officer Director Jim Flynn c/o Deerfield Management Company LP 1345 Park Avenue South New York NY NEW YORK 10010 Director Martin Heidecker c/o Deerfield Management Company LP 1345 Park Avenue South New York NY NEW YORK 10010 Director Jonathan Leff c/o Deerfield Management Company LP 1345 Park Avenue South New York NY NEW YORK 10010 Director Biotechnology Decline to Disclose 06b false 2024-06-11 true true false 0 83835000 25436790 58398210 false 6 0 0 0 true false Elion Therapeutics, Inc. /s/ Jonathan Simansky Jonathan Simansky Assistant Corporate Secretary 2024-06-26